Denosumab in Subjects With Giant Cell Rich Tumors of Bone

NCT03605199 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Aneurysmal Bone Cysts
Giant Cell Granuloma
Osteoblastoma
Chondroblastoma
Chondromyxoid Fibroma

Interventions

DRUG: Denosumab

Sponsor

Leiden University Medical Center

Collaborators

[object Object]